Stemtech Corp

Stemtech Corp develops and markets stem cell nutrition and personal care products, including dietary supplements, toothpaste, and skin-care items sold under proprietary brands. The company operates through a network marketing model that combines independent business partners with direct-to-consumer distribution, with activity in the United States and selected international markets.

−88,4 %

80,3 %

−140,7 %

−43,1 %

0.04

0.02

— Stemtech Corp
%
Dietary supplements55% Natural, patented supplements positioned around stem cell nutrition and adult stem cell support.
Oral care15% OraStem® toothpaste and related oral hygiene products sold through the company’s distribution network.
Skin care10% Cellect One® Rapid Renew night cream and other topical personal care products.
Network marketing distribution20% Sales generated through independent business partners and direct-to-consumer channels.

Stemtech sells primarily to wellness-oriented consumers who buy supplements and personal care products marketed around...

  • Wellness consumersprimary

    Buy dietary supplements and related products for perceived health and stem cell support.

  • Independent Business Partnersprimary

    Purchase and promote products within the network marketing system to earn commissions.

  • Direct-to-consumer customerssecondary

    Order products online or through recurring shipments without joining the sales network.

  • Oral care customerssecondary

    Buy OraStem® toothpaste for whitening, breath freshening, and gum-care benefits.

  • Skin-care customersemerging

    Buy Cellect One® night cream and similar products for topical personal-care use.

Stemtech is headquartered in the United States but markets its products through a model designed to operate across...

  • •United States is the home market and corporate base
  • •India is a strategic growth market through a majority-owned joint venture
  • •Taiwan is served through an exclusive distribution and licensing agreement
  • •Mexico is used for fulfillment and customer service operations
  • •The model is designed for cross-border direct selling and e-commerce

Stemtech’s strategy centers on expanding its distributor network, broadening international reach, and using asset-light...

01
Grow the independent business partner baseshort-term

The network marketing model depends on active distributors to generate sales and recruit customers.

02
Expand international market access through partnershipsmedium-term

Joint ventures and licensing provide geographic reach without heavy upfront investment.

03
Improve fulfillment and working-capital efficiencyshort-term

Inventory availability and order fulfillment directly affect sales continuity in a product-driven network model.

Stemtech faces execution risk from its dependence on distributor recruitment, product availability, and working-capital...

high

Liquidity and working-capital dependence

The company states it needs additional capital and inventory financing to support operations and sales continuity.

Scope
Inventory availability and order fulfillment
Materiality
high
high

Distributor network concentration and churn

Sales depend on independent business partners, so weak recruitment or retention can reduce orders.

Scope
IBP-driven revenue generation
Materiality
high
high

Supply chain and out-of-stock risk

Inventory shortages can defer sales and interrupt recurring customer shipments.

Scope
Product availability and fulfillment cycles
Materiality
high
medium

Regulatory and reputational risk around product claims

Supplements and stem-cell-related marketing can attract scrutiny if claims are challenged.

Scope
Nutrition, oral care, and skin-care marketing
Materiality
high
medium

International execution risk

Joint ventures and licensing agreements require local compliance, partner alignment, and channel build-out.

Scope
India and Taiwan expansion
Materiality
medium
Revenue recognition and shipment timing
Quarterly comparability
Going-concern assessment
Asset and liability classification judgments
Convertible notes and warrants
Earnings and equity dilution
Inventory and fulfillment estimates
Cost of sales and working capital

International Stem Cell CORP

ISCO · Pharmaceutical Preparations

MANNATECH INC

MTEX · Medicinal Chemicals & Botanical Products

STEM, INC.

STEM · Services-Computer Integrated Systems Design

NovelStem International Corp.

NSTM · Retail-Retail Stores, NEC

Regenerative Medical Technology Group Inc.

RMTG · Retail-Retail Stores, NEC

Stimcell Energetics Inc.

STME · Surgical & Medical Instruments & Apparatus

: 29/04/2026